| Autor: |
Raderer M; Department of Internal Medicine I, University of Vienna, Austria., Hejna MH, Kurtaran A, Kornek GV, Valencak JB, Oberhuber G, Vorbeck F, Virgolini I, Scheithauer W |
| Jazyk: |
angličtina |
| Zdroj: |
The American journal of gastroenterology [Am J Gastroenterol] 1999 Jan; Vol. 94 (1), pp. 278-9. |
| DOI: |
10.1111/j.1572-0241.1999.00821.x |
| Abstrakt: |
Treatment options for hepatocellular cancer apart from surgical resection are limited because of the drug-refractory nature of this disease. Little is known about the role of somatostatin-receptors in hepatocellular cancer, and somatostatin analogs have not been investigated for treatment of this malignancy. We present the case of a 68-yr-old male, who was successfully treated with the long-acting somatostatin analog lanreotide. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
